Apri For Hepatitis C Cirrhosis Probability

ورودی‌های بالینی بیمار

حداقل ۱ — حداکثر ۵۰۰۰ • واحد: U/L

حداقل ۱۰ — حداکثر ۱۰۰ • واحد: U/L

حداقل ۱۰ — حداکثر ۱۰۰۰ • واحد: x10^3/uL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
apri
—index
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Cirrhosis likely≥ 2
  • Significant fibrosis≥ 1
  • Low≥ 0
Direct Clinical Answer

The Apri For Hepatitis C Cirrhosis Probability calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include ast. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

APRI: AST-to-platelet ratio index for liver fibrosis in hepatitis C.

Clinical Indication

The Apri For Hepatitis C Cirrhosis Probability is indicated for bedside clinical practice to support APRI: AST-to-platelet ratio index for liver fibrosis in hepatitis C.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.

Formula & Variables:

APRI = (AST/ULN) / platelets(x10^9/L) x 100

Input Parameters

NameTypeRequiredDescription
astfloatYesAST (1-5000 U/L)(U/L)
ast_ulnfloatYesAST upper limit of normal (10-100 U/L)(U/L)
plateletsfloatYesPlatelet count (10-1000 x10^3/uL)(x10^3/uL)

Score Interpretation & Guidance

RangeStageDescription
≥ 2Cirrhosis likelyCirrhosis likely
≥ 1Significant fibrosisSignificant fibrosis possible
≥ 0LowSignificant fibrosis unlikely

Evidence-Based References (EBM)

  • Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518-526.

Related calculators